Abstract
Flavonoids are secondary metabolites produced in plants that have diverse biological activities. The present review summarizes information gathered mostly in the last six years on the flavonoids structure-activity relationships, specifically with respect to: A) phytoestrogenic activity – flavonoids potential to replace estrogen during the menopausal period and especially fascinating, the possibility of finding flavonoids selective for estrogen receptor β; B) as antioxidants – their potential to treat oxidative stress-associated diseases; C) as whitening agents – potentially active via their ability to inhibit the enzyme tyrosinase; D) flavonoids that are active due to their interaction with proteins (enzymes, receptors, transporters and transcription factors), an area which we believe will attract much more attention in the near future, in helping to understand the role of flavonoids and their mechanism of action in the treatment of human diseases. This review covers data collected from experiments performed using flavonoids with known structure rather than crude extracts, and in the first two sections (A and B), the focus is on results obtained from in-vivo experiments, where available.
Keywords: Antioxidants, Flavonoids, Phytoestrogen, Protein interaction, Whitening agent, phytoestrogenic activity, hormone-replacement therapy (HRT), estrogen receptors (ER), agonism, ER -selective antagonists, QSAR Models, Docking Analysis, Superposition Analysis, SERM, thiobarbitoric reactive substances (TBARS)
Current Organic Chemistry
Title: Structure-Activity Relationships of Flavonoids
Volume: 15 Issue: 15
Author(s): Vaya Jacob, Tavori Hagai and Khatib Soliman
Affiliation:
Keywords: Antioxidants, Flavonoids, Phytoestrogen, Protein interaction, Whitening agent, phytoestrogenic activity, hormone-replacement therapy (HRT), estrogen receptors (ER), agonism, ER -selective antagonists, QSAR Models, Docking Analysis, Superposition Analysis, SERM, thiobarbitoric reactive substances (TBARS)
Abstract: Flavonoids are secondary metabolites produced in plants that have diverse biological activities. The present review summarizes information gathered mostly in the last six years on the flavonoids structure-activity relationships, specifically with respect to: A) phytoestrogenic activity – flavonoids potential to replace estrogen during the menopausal period and especially fascinating, the possibility of finding flavonoids selective for estrogen receptor β; B) as antioxidants – their potential to treat oxidative stress-associated diseases; C) as whitening agents – potentially active via their ability to inhibit the enzyme tyrosinase; D) flavonoids that are active due to their interaction with proteins (enzymes, receptors, transporters and transcription factors), an area which we believe will attract much more attention in the near future, in helping to understand the role of flavonoids and their mechanism of action in the treatment of human diseases. This review covers data collected from experiments performed using flavonoids with known structure rather than crude extracts, and in the first two sections (A and B), the focus is on results obtained from in-vivo experiments, where available.
Export Options
About this article
Cite this article as:
Jacob Vaya, Hagai Tavori and Soliman Khatib, Structure-Activity Relationships of Flavonoids, Current Organic Chemistry 2011; 15 (15) . https://dx.doi.org/10.2174/138527211796367309
DOI https://dx.doi.org/10.2174/138527211796367309 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Can the Electrophysiological Action of Rosiglitazone Explain its Cardiac Side Effects?
Current Medicinal Chemistry The State of the Problem of Achieving Extremely Low LDL Levels
Current Pharmaceutical Design Fabrication and Physicochemical and Medicinal Characterization of Nano Traditional Chinese Medicine
Recent Patents on Engineering Development of Gene Therapies for Cardiovascular and Renal Diseases by Nucleic Acid Medicines
Medicinal Chemistry Resveratrol and Cardiovascular Disease
Current Nutrition & Food Science Systemic Sclerosis: Clinical Manifestations
Current Rheumatology Reviews Synthetic Genomics and Synthetic Biology Applications Between Hopes and Concerns
Current Genomics RAGE in Diabetic Nephropathy
Current Molecular Medicine Can microRNAs be Biomarkers or Targets for Therapy of Ischemic Coronary Artery Disease in Metabolic Syndrome?
Current Drug Targets Editorial (Thematic Issue: The Changing Face of Metabolic Syndrome and its Components in the Light of Current Knowledge)
Current Vascular Pharmacology COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Current Rheumatology Reviews Mechanisms of Protective Effects of SGLT2 Inhibitors in Cardiovascular Disease and Renal Dysfunction
Current Topics in Medicinal Chemistry Diabetic Cardiomyopathy and its Prevention by Metallothionein: Experimental Evidence, Possible Mechanisms and Clinical Implications
Current Medicinal Chemistry Clinical Relevance of Postprandial Lipaemia
Current Medicinal Chemistry Increased Exercise Favorably Modifies Coronary Artery Disease and Peripheral Arterial Disease Outcomes
Current Vascular Pharmacology Natriuretic Peptide Family: New Aspects
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Bile Acid Reabsorption Inhibitors (BARI): Novel Hypolipidemic Drugs
Current Medicinal Chemistry Insights Into Early and Rapid Effects of Statin Therapy after Coronary Interventions
Current Pharmaceutical Design Recent Developments in Drug Design of NO-donor Hybrid Compounds
Mini-Reviews in Medicinal Chemistry Endogenous Cardioprotective Agents: Role in Pre and Postconditioning
Current Drug Targets